How Does bluebird bio Inc (BLUE) Stock Rank on Wall Street Tuesday?

Wall Street is positive on bluebird bio Inc (BLUE). On average, analysts give the stock a Hold rating. The average price target is $7, which means analysts expect the stock to increase by 4.17% over the next twelve months. That average ranking earns the stock an Analyst Rating of 3, which is better than 3% of stocks based on data compiled by InvestorsObserver.

Wall Street analysts are rating BLUE a Hold today. Find out what this means to you and get the rest of the rankings on BLUE!

See Full BLUE Report

Why are Analyst Ratings Important?

Analysts know the inner workings of the companies they follow better than anyone but the companies’ management. You can learn a lot about a company from studying the financial statements, but analysts ask questions on conference calls and understand the intricacies of each of the businesses they cover. Analysts understand how bad weather in one part of the world can disrupt supply chains, or disrupt shopping patterns. This lets traders make decisions before a quarterly report that could be worse than expected. InvestorsObserver aggregates the ratings of all the analysts covering a given stock, takes the average of those ratings and then percentile ranks the averages. That provides a level of granularity that is significantly better than just the three levels provided by traditional buy/hold/sell ratings.

What's Happening With bluebird bio Inc Stock Today?

bluebird bio Inc (BLUE) stock is trading at $6.72 as of 10:50 AM on Tuesday, Oct 18, a gain of $0.02, or 0.3% from the previous closing price of $6.70. The stock has traded between $6.65 and $6.96 so far today. Volume today is light. So far 786,795 shares have traded compared to average volume of 7,909,518 shares. Click Here to get the full Stock Report for bluebird bio Inc stock.